North Tide Capital’s Syneron Medical Ltd ELOS Stock Holding History

North Tide Capital’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,000,000	Closed	-$31.6M	–	17
2017 Q1	$31.6M	Sell	3,000,000 -500,000	-14%	-$4.84M	4.86%	11
2016 Q4	$29.4M	Hold	3,500,000	–	–	5.03%	6
2016 Q3	$25.1M	Hold	3,500,000	–	–	2.73%	12
2016 Q2	$26.9M	Hold	3,500,000	–	–	3%	13
2016 Q1	$25.6M	Hold	3,500,000	–	–	2.77%	10
2015 Q4	$27M	Buy	3,500,000 +500,000	+17%	+$3.81M	2.69%	13
2015 Q3	$21.4M	Hold	3,000,000	–	–	1.87%	13
2015 Q2	$31.9M	Hold	3,000,000	–	–	2.3%	15
2015 Q1	$37.1M	Hold	3,000,000	–	–	2.81%	15
2014 Q4	$28M	Hold	3,000,000	–	–	1.88%	21
2014 Q3	$30.1M	Hold	3,000,000	–	–	2.29%	18
2014 Q2	$31M	Buy	3,000,000 +539,700	+22%	+$5.83M	2.17%	20
2014 Q1	$30.6M	Buy	2,460,300 +110,300	+5%	+$1.31M	2.58%	14
2013 Q4	$28.9M	Buy	2,350,000 +200,000	+9%	+$2.08M	2.53%	17
2013 Q3	$18.5M	Buy	2,150,000 +650,000	+43%	+$5.61M	1.94%	17
2013 Q2	$13.1M	Buy	+1,500,000	New	+$13.4M	2.31%	16

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

North Tide Capital's ELOS Position: Q2 2017 in Review

North Tide Capital sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 3,000,000 shares — an estimated $31.6M sold.

North Tide Capital first reported a position in ELOS in Q2 2013 and held it in 16 quarters. The position peaked at $37.1M in Q1 2015. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

North Tide Capital reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
North Tide Capital sold 3,000,000 Syneron Medical Ltd shares in Q2 2017, an estimated $31.6M.
North Tide Capital first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 16 quarters.
North Tide Capital's Syneron Medical Ltd position peaked at $37.1M in Q1 2015.
79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on North Tide Capital's 13F filing for Q2 2017, filed 14 Aug 2017.